Prize for the most complete answer - (Link to Original Letter)
Dear Mr Cahm
Freestyle Libre
I write further to your letter of 21st March 2019 in which you asked the following two questions:
1. Your plans for meeting the NHS England Libre policy
2. How the Libre prescribing process will be handled? Will it be Red, Amber or Green listed?
In February 2019 a Leicester, Leicestershire and Rutland prescribing position statement was issued onto the Leicestershire Medicines Strategy Group (LMSG) website. This took effect from 1st February 2019 to 31st March 2019.’Freestyle Libre® is approved for use in Leicester Leicestershire and Rutland from 1st February 2019 where a patient meets the following criteria detailed in the RMOC guidelines for the use of this product.’
This was issued following the RMOC guidance and further to this, the necessary documents to support this were made available on LMSG website. The link to the most current guidance is below.
https://www.lmsg.nhs.uk/traffic-lights/view/1122/
In your letter you have identified that the December 2018 data the CCG was prescribing freestyle libre to 0.3% of the total Type 1diabetes patient population. However our change in advice in line with the RMOC guidance was only implemented in February 2019 and therefore the data was pre date the change in our current prescribing position which since December 2018 has moved towards implementation of the RMOC guidance.
In respect of the announcements from NHSE in February and further announcements more recently around Freestyle Libre funding, the CCG is aware of the national funding announced by NHSE and the process is currently being reviewed across Leicester, Leicestershire and Rutland and will be updated on LMSG as soon as this has been agreed
I hope this responds to your enquiry.
Dear Mr Cahm
Freestyle Libre
I write further to your letter of 21st March 2019 in which you asked the following two questions:
1. Your plans for meeting the NHS England Libre policy
2. How the Libre prescribing process will be handled? Will it be Red, Amber or Green listed?
In February 2019 a Leicester, Leicestershire and Rutland prescribing position statement was issued onto the Leicestershire Medicines Strategy Group (LMSG) website. This took effect from 1st February 2019 to 31st March 2019.’Freestyle Libre® is approved for use in Leicester Leicestershire and Rutland from 1st February 2019 where a patient meets the following criteria detailed in the RMOC guidelines for the use of this product.’
This was issued following the RMOC guidance and further to this, the necessary documents to support this were made available on LMSG website. The link to the most current guidance is below.
https://www.lmsg.nhs.uk/traffic-lights/view/1122/
In your letter you have identified that the December 2018 data the CCG was prescribing freestyle libre to 0.3% of the total Type 1diabetes patient population. However our change in advice in line with the RMOC guidance was only implemented in February 2019 and therefore the data was pre date the change in our current prescribing position which since December 2018 has moved towards implementation of the RMOC guidance.
In respect of the announcements from NHSE in February and further announcements more recently around Freestyle Libre funding, the CCG is aware of the national funding announced by NHSE and the process is currently being reviewed across Leicester, Leicestershire and Rutland and will be updated on LMSG as soon as this has been agreed
I hope this responds to your enquiry.
Comments